Atypical fibroxanthoma and squamous cell carcinoma of the conjunctiva in xeroderma pigmentosum

Pediatric and Developmental Pathology

Volumn 10, Issue 2, 2007, Pages 149-152

  Shao, Lei ^a   Newell, Brandon ^a   Quintanilla, Norma ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Atypical fibroxanthoma; Squamous cell carcinoma; Xeroderma pigmentosum

Indexed keywords

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVA TUMOR; EYE EXAMINATION; FIBROXANTHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; XERODERMA PIGMENTOSUM;

AFRICAN AMERICANS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, SQUAMOUS CELL; CHILD, PRESCHOOL; CONJUNCTIVA; FOLLOW-UP STUDIES; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; VIMENTIN; XERODERMA PIGMENTOSUM;

EID: 34147216867     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-06-0103.1     Document Type: Article

References (17)

1. Jung EG. Xeroderma pigmentosum. Int J Dermatol 1986;25:629-633.
2. Kraemer KH, Lee M, Scotto J. Xeroderma pigmentosum-cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241-250.
3. Hertle RW, Durso F, Metzler JP, Varsa EW. Epibulbar squamous cell carcinomas in brothers with xeroderma pigmentosa. J Pediatr Ophthalmol Strabismus 1991;28:350-353.
4. Goyal JL, Rao VA, Srinivasan R, et al. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994;78:295-297.
5. Khatri ML, Bemghazil M, Shafi M, et al. Xeroderma pigmentosum in Libya. Int J Dermatol. 1999;38:520-524.
6. Dilek FH, Akpolat N, Metin A, Ugras S. Atypical fibroxanthoma of the skin and the lower lip in xeroderma pigmentosum. Br J Dermatol 2000;143:618-620.
7. Youssef N, Vabres P, Buisson T, et al. Two unusual tumors in a patient with xeroderma pigmentosum: atypical fibroxanthoma and basosquamous carcinoma. J Cutan Pathol 1999;26:430-435.
8. Patterson JW, Jordan WP Jr. Atypical fibroxanthoma in a patient with xeroderma pigmentosum. Arch Dermatol 1987;123:1066-1070.
9. Jacyk WK. Xeroderma pigmentosum in black South Africans. Int J Dermatol.1999;38:511-514.
10. Ahmed H, Hassan RY, Pindiga UH. Xeroderma pigmentosum in three consecutive siblings of a Nigerian family: observations on oculocutaneous manifestations in black African children. Br J Ophthalmol 2001;85:110-111.
11. Pe'er J, Levinger S, Ilsar M, et al. Malignant fibrous histiocytoma of the conjunctiva. Br J Ophthalmol 1990;74:624-628.
12. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973;31:1541-1552.
13. Monteagudo C, Calduch L, Navarro S, et al. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002;117:126-131.
14. Weedon D, Williamson R, Mirza B. CD10, a useful marker for atypical fibroxanthoma. Am J Dermatopathol 2005;27:181.
15. Dei Tos AP, Maestro R, Doglioni C, et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994;145:11-17.
16. Sakamoto A, Oda Y, Itakura E, et al. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Mod Pathol 2001;14: 581-588.
17. Kaddu S, McMenamin ME, Fletcher CD. Atypical fibrous histiocytoma of the skin: clinicopathologic analysis of 59 cases with evidence of infrequent metastasis. Am J Surg Pathol 2002;26:35-46.